Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05873465 · ClinicalTrials.gov registry record · Phase 4
Cannabis Use on Sedation for Oral Surgery Procedures
A Phase 4 study of Cannabis Use, sponsored by University of Oklahoma.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05873465: Recruiting Phase 4 study of Cannabis Use, sponsored by University of Oklahoma.
NCT05873465 is a Phase 4 study of Cannabis Use that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 60 participants, below the 278-participant average among 44 other Cannabis Use trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05873465, a Phase 4 study of Cannabis Use, is actively recruiting participants, sponsored by University of Oklahoma.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The use of Cannabis is increasing in the population, and the effects that this might have on different medical procedures are poorly understood. Particularly when submitted to deep sedation or general anesthesia, there is no consensus on best drugs or doses to deliver. The purpose of this clinical trial is to clarify the influence of chronic cannabis use during office based general anesthesia for extraction of teeth. The procedures will be performed in the Oral and Maxillofacial Surgery Clinic at the College of Dentistry.
Conditions Studied
Interventions
- DRUG Sedation with Midazolam, Fentanyl, and Propofol
- PROCEDURE Extraction of teeth
Study Locations (1)
Oklahoma
- College of Dentistry - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-03-14 |
| Est. Completion | 2025-06-30 |
| Phase | Phase 4 |
What NCT05873465 shows while recruiting
NCT05873465 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 278-participant average among 44 other Cannabis Use trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Cannabis Use appearing as the primary indexed condition, and to 2 interventions - of which Sedation with Midazolam, Fentanyl, and Propofol is the first listed.
NCT05873465 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT05873465 about?
NCT05873465 is a clinical study titled "Cannabis Use on Sedation for Oral Surgery Procedures". The use of Cannabis is increasing in the population, and the effects that this might have on different medical procedures are poorly understood. Particularly when submitted to deep sedation or general anesthesia, there is no consensus on best drugs or doses to deliver. The purpose of this clinical t...
What is the current status of trial NCT05873465?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2023-03-14. Estimated completion is 2025-06-30.
What conditions does trial NCT05873465 study?
This clinical trial studies the following conditions: Cannabis Use.
What interventions are being tested in trial NCT05873465?
The interventions under investigation include: Sedation with Midazolam, Fentanyl, and Propofol (DRUG), Extraction of teeth (PROCEDURE).
Who is sponsoring clinical trial NCT05873465?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05873465 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05873465's enrollment target sits among peer trials
60 31st of 44 higher than 12 of 44 other Cannabis Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cannabis Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Pregnancy-associated Hormones on THC Metabolism in Women
ACTIVE NOT RECRUITING · Phase 4
-
Feasibility/Acceptability of a Brief Motivational Intervention for Frequent/High-Intensity Cannabis Use
RECRUITING · NA
-
Effect of Cannabis on Cigarette Use Behavior
RECRUITING · Phase 1
-
SV2A in Older Adults
RECRUITING · Phase 1
-
Cannabis' Impact on Alcohol Consumption
RECRUITING · Phase 2
-
Distinguishing Alcohol Intoxication, Cannabis Intoxication and Co-intoxication Using Electroencephalography (EEG)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI